Biomarkers and atrial fibrillation: A new paradigm for assessing the progression of left atrial endocardial remodelling
Atrial Fibrillation Wednesday, July 11th, 2012Scirp.org: 6/19/12 Atrial fibrillation is a heterogeneous disorder that is usually characterized by paroxysmal onset, particularly in patients without structural heart disease. Defining biological markers of atrial remodelling would help identify patients at high risk who would benefit most from prophylactic treatment and careful monitoring. Biomarkers of atrial fibrillation progression would be helpful for following patients […]